ARCHIVES

Study Validates “PEM” Scans As Biopsy Guidance Method

This article is from The Cancer Letter archive.

Vol. 34 No. 4 | April 29, 2011

Download PDF Visit The Full Archive

Related Articles

New Cyclotron Delivered To University of Maryland, Instigating D.C.-Area Proton Radiation Competition

June 20, 2014

FDA Sets High Bar for Prevention Agents as ODAC Votes Down Proscar And Avodart

December 3, 2010

Freestanding Cancer Centers May Be The “Missing Ingredient In Cancer Treatment,” DeVita Believes

January 11, 1985

BioSeek Awarded NIH SBIR For Compound Validation.

July 4, 2003

Sandra Swain Is Acting Chief Of NCI’s Medicine Branch.

July 21, 2000

Advisors Reaffirm Survival As Standard For full FDA Approval Of Cancer Drugs

June 16, 1999